Literature DB >> 7566534

Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage.

Y Fujii1, A Takahashi, T Yoshimoto.   

Abstract

Of 455 cases of ruptured intracranial aneurysm treated with radical surgery from January 1987 to March 1992, 19 cases with high grade symptomatic vasospasm were treated by percutaneous transluminal balloon angioplasty (PTA). The indication for PTA was high grade symptomatic vasospasm which does not respond to conservative medical treatment. Of the 36 segments of vasospastic arteries, severe vasospasm (angiographical constriction more than 50% of diameter on admission) was observed in 67%. PTA dilated these vasospastic arteries significantly (diameter of more than 75% of diameter on admission) in 83%. Follow up angiography revealed neither recurrence of vasospasm nor chronic atherosclerotic changes. Clinical improvement within 24 hours after PTA was observed in 63% of cases (7 of 17 cases with consciousness disturbance, 5 of 16 cases with motor weakness and one of 7 cases with aphasia). Outcomes at the time of discharge were excellent in 10 cases, good in 3, fair in 4, and lethal in 2. SPECT study before and after PTA confirmed improvement of cerebral blood flow in 3 out of 5 cases investigated. PTA for high grade symptomatic vasospasm after subarachnoid hemorrhage is considered an effective treatment method for the patient who does not respond to medical therapy. Immediate improvement of angiographical and clinical findings were frequently observed immediately after PTA. Exact indication and timing of PTA should be postulated after much more cases have been treated with this methal.

Entities:  

Mesh:

Year:  1995        PMID: 7566534     DOI: 10.1007/BF00416470

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  12 in total

1.  Morphological changes in normal canine basilar arteries after transluminal angioplasty.

Authors:  L Chàvez; A Takahashi; T Yoshimoto; C C Su; T Sugawara; Y Fujii
Journal:  Neurol Res       Date:  1990-03       Impact factor: 2.448

2.  Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH.

Authors:  Y N Zubkov; B M Nikiforov; V A Shustin
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

3.  Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage.

Authors:  D W Newell; J M Eskridge; M R Mayberg; M S Grady; H R Winn
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

4.  Transluminal angioplasty for treatment of intracranial arterial vasospasm.

Authors:  R T Higashida; V V Halbach; L D Cahan; M Brant-Zawadzki; S Barnwell; C Dowd; G B Hieshima
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

5.  Balloon embolization of a large distal basilar artery aneurysm. Case report.

Authors:  G B Hieshima; R T Higashida; J Wapenski; V V Halbach; L Cahan; J R Bentson
Journal:  J Neurosurg       Date:  1986-09       Impact factor: 5.115

6.  Cerebral vasodilation and prostacyclin. The effects of aspirin and meclofenamate in vitro.

Authors:  C E Chapleau; R P White; J T Robertson
Journal:  J Neurosurg       Date:  1980-08       Impact factor: 5.115

7.  Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.

Authors:  K Mizoi; T Yoshimoto; S Fujiwara; T Sugawara; A Takahashi; K Koshu
Journal:  Neurosurgery       Date:  1991-06       Impact factor: 4.654

8.  Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.

Authors:  J M Findlay; B K Weir; D Steinke; T Tanabe; P Gordon; M Grace
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

9.  Prevention of vasospasm by early operation with removal of subarachnoid blood.

Authors:  M Mizukami; T Kawase; T Usami; T Tazawa
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

10.  Protective effect of phenytoin and its enhanced action by combined administration with mannitol and vitamin E in cerebral ischaemia.

Authors:  J Suzuki; H Abiko; K Mizoi; M Oba; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

View more
  4 in total

Review 1.  Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  M Kamran Athar; Joshua M Levine
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Critical care guidelines on the endovascular management of cerebral vasospasm.

Authors:  Matthew M Kimball; Gregory J Velat; Brian L Hoh
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

3.  Safety and efficacy of balloon angioplasty of the anterior cerebral artery for vasospasm treatment after subarachnoid hemorrhage.

Authors:  Nauman S Chaudhry; Jennifer L Orning; Sophia F Shakur; Sepideh Amin-Hanjani; Victor A Aletich; Fady T Charbel; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2017-03-24       Impact factor: 1.610

4.  Angioplasty with the scepter C dual lumen balloon catheter and postprocedural result evaluation in patients with subarachnoid hemorrhage related vasospasms.

Authors:  Ioannis Tsogkas; Vesna Malinova; Katharina Schregel; Dorothee Mielke; Daniel Behme; Veit Rohde; Michael Knauth; Marios-Nikos Psychogios
Journal:  BMC Neurol       Date:  2020-06-29       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.